Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

Université Laval

$150,000.00

Impact of epigenetic markers of breast adipose tissue on the efficacy of aromatase inhibitors treatments.

FY 2016-17

Summary
Breast cancer and obesity are both major health concerns in developed countries. Obesity results from complex interactions between genetic and environmental factors, and is now well recognized to increase breast cancer risk and mortality. In fact, after menopause, fatty tissue is the main source of female hormones, particularly estrogens, and about 80% of breast cancers are hormone dependant, i.e. breast cancer cells need estrogens to grow and multiply. One of the standard treatments for these types of breast cancers, called aromatase inhibitors, blocks the production of estrogens in fatty tissues. Thus, obesity may interfere with efficacy of this hormonal treatment. Actually, differences in hormonal treatment efficiency have been observed, particularly in obese women, and this phenomenon could be explained by differences in genes activation in their breast fat tissue. Genes can be activated by several mechanisms called epigenetic events. Epigenetic events are reversible chemical modifications of DNA that regulate activity of genes depending on the function of the cell and its environment. Obesity may affect breast cancer treatment efficiency through these epigenetic events, especially through a mechanism called DNA methylation. Interestingly, this mechanism can be reversed, making it an appealing target for breast cancer treatment. However, nothing is known about how patterns of this DNA methylation mechanism in breast fat tissues may relate to hormonal treatment efficacy. The objective of the present project is to address the hypothesis that breast fat tissue of women before treatment contains a number of hypo-methylated or hyper-methylated genes that can predict response to hormonal treatment. Therefore, by studying differences in genes activation markers in breast fat tissue of several breast cancer patients, we aim to develop personalized treatments that could increase hormonal treatment efficacy and eventually improve breast cancer survival.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
362464
Name
Ennour-Idrissi Kaoutar
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Impact of epigenetic markers of breast adipose tissue on the efficacy of aromatase inhibitors treatments.
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Adipose Tissue; Aromatase Inhibitors; Breast Cancer; Epigenetics; Estrogens; Genome-Wide; Methylation; Obesity; Pcr
Abstract
Breast cancer and obesity are both major health concerns in developed countries. Obesity results from complex interactions between genetic and environmental factors, and is now well recognized to increase breast cancer risk and mortality. In fact, after menopause, fatty tissue is the main source of female hormones, particularly estrogens, and about 80% of breast cancers are hormone dependant, i.e. breast cancer cells need estrogens to grow and multiply. One of the standard treatments for these types of breast cancers, called aromatase inhibitors, blocks the production of estrogens in fatty tissues. Thus, obesity may interfere with efficacy of this hormonal treatment. Actually, differences in hormonal treatment efficiency have been observed, particularly in obese women, and this phenomenon could be explained by differences in genes activation in their breast fat tissue. Genes can be activated by several mechanisms called epigenetic events. Epigenetic events are reversible chemical modifications of DNA that regulate activity of genes depending on the function of the cell and its environment. Obesity may affect breast cancer treatment efficiency through these epigenetic events, especially through a mechanism called DNA methylation. Interestingly, this mechanism can be reversed, making it an appealing target for breast cancer treatment. However, nothing is known about how patterns of this DNA methylation mechanism in breast fat tissues may relate to hormonal treatment efficacy. The objective of the present project is to address the hypothesis that breast fat tissue of women before treatment contains a number of hypo-methylated or hyper-methylated genes that can predict response to hormonal treatment. Therefore, by studying differences in genes activation markers in breast fat tissue of several breast cancer patients, we aim to develop personalized treatments that could increase hormonal treatment efficacy and eventually improve breast cancer survival.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ennour-Idrissi, Kaoutar
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Université Laval - $150,000 Grant (2016-17) | Canada Spends